Figure 4F shows that the levels of E2F1, PTEN, and CDKN1A were decreased in HCC tissue samples, and E2F1 and CDKN1A in NASH/fibrotic tissue. This evidence concerns the gene PTEN and metabolic dysfunction-associated steatohepatitis.